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http://dx.doi.org/10.1016/j.jmii.2012Background: Nasal irrigation has been used as adjunctive therapy for sinonasal disease but is
under-researched in children. The study aim was to evaluate the effectiveness of nasal irriga-
tion with normal saline in the management of acute sinusitis in atopic children.
Methods: We enrolled 60 atopic children with acute sinusitis, of whom 29 received nasal irriga-
tion with normal saline and 31 did not receive nasal irrigation. All participants underwent a nasal
peak expiratory flow rate (nPEFR) test, a nasal smear examination, and radiography (Water’s
projection) and were requested to complete a Pediatric Rhinoconjunctivitis Quality-of-Life
Questionnaire (PRQLQ) during the baseline visit. All participants were requested to record
symptoms in a daily diary andwere followed up at 1-week intervals. A physical examination, nasal
smear, and nPEFR were performed at each visit, and all daily diaries were collected. At the final
visit (after 3 weeks), the symptom diaries were reviewed and participants were requested to
complete the PRQLQ again. nPEFR, radiography, and a nasal smear were also repeated.
Results: Therewere significant improvements inmean PRQLQ and nPEFR values (p< 0.05) for the
irrigation compared to the non-irrigation group. There was no significant difference in radio-
graphic findings between the groups (p> 0.05). The irrigation group recorded significant improve-
ments in eye congestion, rhinorrhea, nasal itching, sneezing, and cough symptoms comparedwith
the non-irrigation group.
Conclusion: Nasal irrigation is an effective adjunctive treatment for acute sinusitis in atopic chil-
dren.
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meniscus in the sinus or complete opacity) of one or bothAtopy in children is a state in which specific IgE antibodies
to common aeroallergens are produced that may be
detected by a skin prick test (SPT) or radio-allergosorbent
test. The role of allergic sensitization is clear in rhinosi-
nusitis, especially chronic sinusitis,1 rhinoconjunctivitis and
asthma. Rachelefsky et al reported that 54% of children
with respiratory allergy had sinusitis as assessed by sinus
radiography.2 In 1992, Furukawa analyzed this study and
a number of other investigations published only as
abstracts, and estimated a concordance between allergy
and sinusitis ranging from 25% to 70%.3 A study in Thailand
revealed that in 100 children with clinically diagnosed
sinusitis and with abnormal paranasal sinus X-rays (the
maxillary sinus was involved in 99% and the ethmoid sinus in
91% of cases), a positive skin test to common aeroallergens
was found in 53% of patients.4 We previously found that 27
of 66 (40.9%) children with acute sinusitis were atopic.5
Sinusitis is a very common condition in children. The main
symptoms associated with rhinosinusitis in children are
cough (during the day or night, but generally worse at
night), rhinorrhea, nasal obstruction, mouth breathing,
hyponasal speech, and snoring. The rhinorrhea can be
purulent but may be clear, minimal, or absent with severe
congestion.6
Several studies have documented interesting results
using nasal irrigation as an adjunctive treatment modality
in many sinonasal diseases (including acute and chronic
sinusitis) and allergic rhinitis.7e13 Nasal irrigation is an
inexpensive, patient-controlled therapy that flushes the
nasal cavity with saline solution, facilitating washing of the
structures within. It augments mucociliary flow, liquefies
tenacious mucus, soothes irritated tissue, augments repair
processes, reduces forceful nose blowing, and improves
olfaction. Our previous study demonstrated that nasal irri-
gation with normal saline is effective in the management of
acute sinusitis in children.5 Some studies have suggested
that atopic patients with sinusitis suffer more severe
symptoms and radiological status.14e16 Moreover, it has
been shown that atopic children are a high-risk group for
the development of allergic diseases.17 The purpose of this
study was to evaluate the effectiveness of nasal irrigation
with normal saline in the management of acute sinusitis in
atopic children.Materials and methods
Participants
The study was conducted at the Division of Allergy, Asthma
and Rheumatology, Department of Pediatrics, Chung Shan
Medical University Hospital, Taichung, Taiwan between
December 2006 and August 2009. Approval for the study
was granted by the Chung Shan Medical University Hospital
Institutional Review Board and written informed parental
consent was obtained before commencing the study. The
inclusion criteria were as follows: (1) a history of recent
upper respiratory infection and purulent nasal discharge
and/or cough (usually nocturnal) for more than 7 days; (2)abnormal findings (mucosal swelling, a horizontal fluid
maxillary sinuses according to Water’s projection; (3)
positive SPT findings for common inhalant allergens; and (4)
a positive atopy history (included atopic dermatitis,
asthma, and allergy rhinitis) based on personal history.
Patients with severe symptoms (longer than 3 months),
a history of any nasal or adenoid surgery, and those with
probable complications (e.g., periorbital swelling) were
excluded. Sixty atopic children with acute sinusitis aged
3e12 years met the inclusion criteria for the study.
Study design
All participants underwent a physical examination, nasal
peak expiratory flow rate (nPEFR) test, nasal smear exam-
ination, and radiography (Water’s projection) and were
requested to complete the Pediatric Rhinoconjunctivitis
Quality-of-Life Questionnaire (PRQLQ) during the baseline
visit. This was a randomized, prospective, placebo-
controlled study. The participants were randomly divided
into two groups: 29 of the 60 participants received standard
treatment (including systemic antibiotics, mucolytics and
nasal decongestants) with nasal irrigation with normal
saline, and the remaining 31 participants received the same
standard treatment alone (placebo group). All participants
were requested to record a symptom diary daily and were
followed up every week for 3 weeks. A physical examina-
tion and nPEFR were performed at each visit, and all daily
diary cards collected.
At the final visit after 3 weeks, the symptom diaries
were reviewed and participants were requested to
complete the PRQLQ again. nPEFR, radiography (Water’s
projection), and nasal smears were also repeated.
Daily diary for nasal symptom scores
Sinusitis symptoms were measured on a scale from 0 to 3 as
follows: 0, none (symptoms not noticeable); 1, mild
(symptoms noticeable but not bothersome); 2, moderate
(symptoms noticeable and bothersome some of the time);
and 3, severe (symptoms bothersome most of the time and/
or very bothersome some of the time). Four nasal symptoms
(rhinorrhea, nasal stuffiness/congestion, nasal itching, and
sneezing) and four non-nasal symptoms (eye itching/
burning, eye tearing/watering, eye redness, and itching of
ears or palate) were recorded by the patients themselves
every day unless they were too young (in general if they
were younger than 6 years), in which case the parents
helped. The total symptom score (TSS) was the sum of the
eight symptom scores recorded. Baseline TSS and each
symptom score were calculated as the mean daily score
during the baseline period of 7 days. Patients were followed
up after 1, 2, and 3 weeks of treatment.
PRQLQ
The PRQLQ has 23 items covering five areas: nasal symp-
toms, ocular symptoms, practical problems, other symp-
toms, and activity limitations. Each item is scored on
a scale from 0 to 6.18 The questionnaire can be completed
Table 1 Demographic characteristics and baseline data
for the two groups
Parameter Irrigation Non-irrigation p
Number 29 31
Sex
Male 18 (62.1) 24 (77.4) 0.31
Female 11 (37.9) 7 (22.6) 0.62
Age
Male 6.12  2.01 6.24  1.84 0.87
Female 6.30  1.24 6.18  2.29 0.99
Height (cm) 118.24  9.74 116.94  10.45 1.00
Weight (kg) 23.36  5.73 22.48  5.36 0.99
Personal history 14 (48.3) 15 (48.4) 0.80
AR 14 (48.3) 13 (41.9) 0.82
AD 2 (6.9) 6 (19.4) 0.30
AS 2 (6.9) 2 (6.5) 0.65
Family history 24 (82.8) 20 (64.5) 0.19
Father
AR 13 (44.8) 11 (35.5) 0.64
AD 3 (10.3) 1 (3.2) 0.56
AS 0 (0) 1 (3.2) 0.97
Mother
AR 10 (34.5) 11 (35.5) 0.85
AD 0 (0) 8 (25.8) 0.01*
AS 1 (3.4) 6 (19.4) 0.13
Siblings
AR 7 (24.1) 6 (19.4) 0.89
AD 1 (3.4) 2 (6.5) 0.95
AS 4 (13.8) 1 (3.2) 0.31
Data are presented as n (%) or mean  SD.
AD Z atopic dermatitis; AR Z allergic rhinitis; AS Z asthma.
* Significant difference between groups at a level of 0.05
(independent t test).
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than 6 years may need parental help.
nPEFR
nPEFR was measured using a Mini-Wright peak expiratory
flow meter equipped with a purpose-built face mask. The
mask was placed on the patient’s face and the seal with the
face was checked. The patient was instructed to blow his/
her nose forcefully after a deep inspiration while sitting
with his/her mouth firmly closed. This test was performed
three times and the highest value was recorded.
Nasal smear
The underside of the patient’s inferior turbinate was rub-
bed with a cotton wool bud and then smeared on a glass
slide. The slides were stained with Leu stain and examined
under a light microscope. An experienced cytologist blin-
ded to clinical status performed the assay. A minimum of
100 leukocytes were counted and the eosinophil and
neutrophil counts were expressed as a proportion of the
total number of leukocytes.
Water’s projection
All 120 sinuses (60 participants) were examined by Water’s
view radiography at baseline and during the final visit. The
radiologist was not aware of the history or clinical findings.
The radiology score for each of the maxillary sinuses was
divided into 32 areas and rated as 0 for opaque and 1 for
normal. Each maxillary sinus was scored separately and the
mean of the two scores was recorded. The score was
compared for baseline (pre-treatment) and final (post-
treatment) radiographs and the percentage improvement
was recorded.
SPT
Before children were enrolled in the study, an SPT was
performed for a standard battery of predefined aero-
allergens (Dermatophagoides pteronyssinus and Dermato-
phagoides farinae) placed on the forearm in a standardized
order. Two experienced allergy nurses performed all tests
using the same standardized procedure. The weal perim-
eter was transferred from the skin to paper using trans-
lucent tape. The results were classified as positive if the
mean diameter was 3 mm or more.
Nasal irrigation
Children assigned to the nasal irrigation group and their
parents were instructed in usage. The children in this group
irrigated each nostril with about 15-20 ml of normal saline
(0.9 g of NaCl in 100 mL of H2O) 1 to 3 times a day during the
treatment period, discontinuing irrigation 2 to 3 days
before the final visit. The normal saline solution was irri-
gated fast upward in a sitting or standing position, with the
head pulled back to allow the secretions to flow downward
from the nose without the patient breathing them in. Thesolution was immediately removed from the nose to mini-
mize any salty or burning feeling.
Statistical analysis
Analyses were carried out using SPSS 12.0 software (SPSS,
Inc., Chicago, IL, USA). All parametric data are expressed
as mean  SD. An independent-sample t test was chosen to
compare radiographic improvement between the groups.
The ManneWhitney U test was used to compare improve-
ments in nPEFR and mean TSS between the groups. It was
also used to compare mean TSS between the two atopy
groups. A p value <0.05 was considered significant.
Results
A total of 60 patients were enrolled and all completed the
study. The mean age was 6 (range 3e12) years. Twenty-nine
patients were assigned to the nasal irrigation group and 31
to the placebo group. There were no significant differences
in baseline demographics and health characteristics
between the groups, including age, sex, height, body
weight, and family and personal history of allergy (allergic
rhinitis, atopic dermatitis, and asthma) (Table 1).
Figure 2. Improvement in Pediatric Rhinoconjunctivitis
Quality-of-Life Questionnaire (PRQLQ) score. The irrigation
group showed a significant improvement in PRQLQ values
compared with the non-irrigation group after 3 weeks of
treatment. *p < 0.05, independent t test.
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nPEFR (t Z 2.96, p < 0.05) and PRQLQ values (t Z 2.053,
p < 0.05) after 3 weeks of treatment compared with the
placebo group (Figs. 1 and 2).
Although there was no significant difference in radio-
graphic improvement between the groups (t Z 0.545,
p > 0.05), the irrigation group experienced a greater
improvement than the placebo group (Fig. 3).
Mean changes in TSS from baseline are shown in Table 2.
There were no significant differences between the groups
except for nasal congestion and sleep quality. However, the
improvement in mean TSS was significantly better in the
irrigation than in the placebo group, with improvements in
rhinorrhea (daytime pZ 0.0027, nocturnal pZ 0.0156) and
cough (daytime pZ 0.0034, nocturnal pZ 0.0192; Tables 3
and 4).
Both groups showed a significant reduction in the
proportion of neutrophils and a significant increase in the
proportion of eosinophils in nasal smears after 3 weeks of
treatment. The cell components of nasal smears did not
significantly differ between the groups.Discussion
This study demonstrates that nasal irrigation with normal
saline is effective in the management of acute sinusitis in
atopic children. There was an improvement in nPEFR
values, mean PRQLQ values, mean TSS, and radiographic
scores. Most clinical trials have shown that nasal irrigation
is effective in children with chronic sinusitis and allergic
rhinitis,10e13 but there have been few clinical trials on the
efficacy in children with acute sinusitis.
This study shows that nasal irrigation is effective in
decreasing symptoms of sinonasal disease and improves
allergic-related quality of life. The exact mechanism of
action of saline nasal irrigation is unknown, but it may
improve nasal mucosa function through several physiolog-
ical effects, including: (1) direct cleansing19,20; (2)
a decrease in mucosal edema; (3) removal of inflammatory
mediators21,22; and (4) improved mucociliary function, asFigure 1. Improvement in nasal peak expiratory flow rate
(nPEFR). The irrigation group showed a significant improve-
ment in nPEFR compared with the non-irrigation group on
intermediate and final dates. *p < 0.05, paired-sample t test.suggested by increased ciliary beat frequency.12,23 The
irrigation group achieved a significant clinical improvement
in quality of life as measured by TSS and PRQLQ. Rabago
et al reported that patients with sinonasal symptoms who
used 2% saline daily in addition to routine care experienced
a 64% improvement in overall symptom severity compared
with patients who used routine care alone.24 Patients also
showed significant improvements in disease-specific quality
of life as measured by the Rhinosinusitis Disability Index
(RSDI), Sinus-Symptom Severity Assessment (SIA), and the
Sino-Nasal Outcomes Test (SNOT-20).25 Our study design
involved self-reporting of nasal and sinus symptoms using
self-report diaries (TSS) and questionnaires (PRQLQ). There
is a possibility that patients over-reported compliance.
However, given the positive study findings, we do not
believe that this was a notable problem.
Several studies have used saline solutions that differed
in tonicity and pH. In our study, irrigation with isotonic
saline (0.9%) was effective for atopic children with acute
sinusitis. It has been shown that hypertonic saline
decreases ciliary movement in human nasal epithelium
in vitro26 and increases mucociliary transit times.27 Homer
et al found that mucociliary clearance results were similar
when using isotonic and 3.0% hypertonic solution, but
observed a decrease in clearance for solutions of 5%Figure 3. Change in radiographic assessment (Water’s
projection). There was no significant difference between the
irrigation and non-irrigation groups (ManneWhitney U test).
Table 2 Comparison of total symptom score between the
groups
Symptom Non-irrigation Irrigation p
(n Z 31) (n Z 29)
Eye itching
Day Wk 1 0.41  0.72 0.37  0.61 0.9440
Day Wk 2 0.30  0.51 0.46  0.71 0.5075
Day Wk 3 0.33  0.55 0.35  0.55 0.7747
Night Wk 1 0.44  0.69 0.39  0.59 0.9744
Night Wk 2 0.27  0.47 0.45  0.74 0.7012
Night Wk 3 0.30  0.57 0.34  0.60 0.5708
Tears
Day Wk 1 0.13  0.47 0.06  0.21 0.4016
Day Wk 2 0.07  0.21 0.09  0.36 0.9103
Day Wk 3 0.08  0.25 0.05  0.20 0.6266
Night Wk 1 0.13  0.46 0.10  0.35 0.6424
Night Wk 2 0.04  0.15 0.07  0.29 0.7111
Night Wk 3 0.08  0.22 0.07  0.24 0.4523
Eye congestion
Day Wk 1 0.13  0.45 0.21  0.54 0.7975
Day Wk 2 0.07  0.23 0.17  0.42 0.2315
Day Wk 3 0.08  0.23 0.12  0.35 0.9818
Night Wk 1 0.04  0.12 0.18  0.53 0.8210
Night Wk 2 0.06  0.21 0.11  0.32 0.3655
Night Wk 3 0.11  0.26 0.11  0.31 0.6851
Rhinorrhea
Day Wk 1 0.81  0.73 0.85  0.67 0.6887
Day Wk 2 0.60  0.68 0.54  0.70 0.7267
Day Wk 3 0.53  0.53 0.57  0.65 0.9695
Night Wk 1 0.80  0.65 0.79  0.61 0.9822
Night Wk 2 0.52  0.54 0.55  0.69 0.8919
Night Wk 3 0.55  0.52 0.47  0.54 0.4471
Nasal congestion
Day Wk 1 1.14  0.74 0.71  0.71 0.0168*
Day Wk 2 0.97  0.77 0.52  0.60 0.0066*
Day Wk 3 0.94  0.75 0.58  0.52 0.0790
Night Wk 1 1.33  0.79 0.66  0.75 0.0012*
Night Wk 2 1.14  0.78 0.65  0.73 0.0085*
Night Wk 3 1.11  0.79 0.61  0.65 0.0208*
Nasal itching
Day Wk 1 0.63  0.70 0.62  0.68 0.9820
Day Wk 2 0.50  0.55 0.49  0.63 0.5952
Day Wk 3 0.53  0.52 0.46  0.58 0.3786
Night Wk 1 0.59  0.63 0.64  0.67 0.8811
Night Wk 2 0.47  0.55 0.50  0.67 0.9435
Night Wk 3 0.57  0.62 0.38  0.56 0.2663
Sneezing
Day Wk 1 0.67  0.43 0.65  0.62 0.3807
Day Wk 2 0.53  0.58 0.54  0.67 0.8333
Day Wk 3 0.60  0.53 0.42  0.54 0.0949
Night Wk 1 0.49  0.48 0.51  0.66 0.6668
Night Wk 2 0.41  0.51 0.41  0.68 0.5310
Night Wk 3 0.48  0.50 0.37  0.54 0.2374
Throat itching
Day Wk 1 0.33  0.53 0.07  0.14 0.1414
Day Wk 2 0.23  0.37 0.05  0.16 0.0976
Day Wk 3 0.23  0.46 0.07  0.18 0.1595
Night Wk 1 0.31  0.44 0.15  0.29 0.0530
Night Wk 2 0.20  0.37 0.07  0.17 0.2912
Night Wk 3 0.28  0.50 0.06  0.20 0.0632
Cough
Day Wk 1 1.17  0.65 0.98  0.61 0.3698
Day Wk 2 0.76  0.56 0.63  0.55 0.3466
Day Wk 3 0.71  0.49 0.52  0.46 0.2085
Night Wk 1 1.09  0.76 0.87  0.56 0.4225
Night Wk 2 0.67  0.70 0.61  0.55 0.9344
Night Wk 3 0.76  0.71 0.44  0.4 0.0628
Sleep quality
Wk 1 0.66  0.67 0.31  0.53 0.0177*
Wk 2 0.59  0.62 0.33  0.55 0.1025
Wk 3 0.47  0.56 0.26  0.46 0.0486*
Daytime sleep
Wk 1 0.31  0.55 0.21  0.41 0.8325
Wk 2 0.19  0.41 0.13  0.32 0.3131
Wk 3 0.18  0.48 0.12  0.31 0.9307
Activity
Wk 1 0.01  0.04 0.09  0.23 0.3429
Wk 2 0.00  0.00 0.00  0.00 1.0000
Wk 3 0.00  0.00 0.05  0.23 0.3272
Data are expressed as mean  SD.
* Significant difference between groups at a level of 0.005
(ManneWhitney U test).
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clearance is similar after irrigation with a solution buffered
to pH 8 or a non-buffered solution. Hence, the common
practice of adding sodium bicarbonate to the irrigating
solution as an alkaline buffer may be of use by increasing
tonicity but not by increasing pH.29 Hypersaline nasal
provocation leads to substance P release and glandular
secretion via stimulation of nociceptive nerves, which can
induce pain in patients.30 In our study, no significant side
effects were recorded in the isotonic saline irrigation
group.Hyperosmolar challenge leads to histamine release
and can be used as a simple diagnostic test for allergic
rhinitis and may provide a model for nasal hyper-reac-
tivity.31 In the same study, isotonic normal saline did not
cause these symptoms to result in hyperosmolar chal-
lenge.31 Similarly, the isotonic saline irrigation group had
no significant side effects in the current study.
Various studies have used different delivery systems,
including bulb syringes, irrigation pots,32 metered dose
pumps, and squeezable bottles with fixed nozzles and
detachable nozzles. In our study, high volumes of solution
were delivered via a syringe (15e20 mL) to irrigate each
nostril, which proved to be effective.5 Similarly, Pynonen
et al found that nasal irrigation performed with a large
volume and delivered with a low positive pressure was more
effective than saline sprays for the treatment of chronic
nasal and sinus symptoms in a community-based
population.33
Nasal saline irrigation reduces inflammatory mediators
(histamine, prostaglandin D2, and leukotriene C4) and
allergens in nasal secretions.22 Therefore, nasal washing
with saline is a cheap and effective method for treating
inflammatory conditions of the upper respiratory tract such
as the common cold, sinusitis, and allergic rhinitis. In our
study, significant decreases and increases in the proportion
of neutrophils and eosinophils, respectively, were observed
in nasal secretions from all participants after 3 weeks. Cell
Table 3 Improvement in total symptom score in the non-
irrigation group (n Z 31)
Symptom Wk 1 Wk 3 p
Eye itching
Day 0.41  0.72 0.33  0.55 0.2392
Night 0.44  0.69 0.30  0.57 0.1056
Tears
Day 0.13  0.47 0.08  0.25 0.2476
Night 0.13  0.46 0.08  0.22 0.4990
Eye congestion
Day 0.13  0.45 0.08  0.23 0.1609
Night 0.04  0.12 0.11  0.26 0.0821
Rhinorrhea
Day 0.81  0.73 0.53  0.53 0.0027*
Night 0.80  0.65 0.55  0.52 0.0156*
Nasal congestion
Day 1.14  0.74 0.94  0.75 0.0914
Night 1.33  0.79 1.11  0.79 0.1941
Nasal itching
Day 0.63  0.70 0.53  0.52 0.3440
Night 0.59  0.63 0.57  0.62 0.9095
Sneezing
Day 0.67  0.43 0.60  0.53 0.3728
Night 0.49  0.48 0.48  0.50 0.9514
Throat itching
Day 0.33  0.53 0.23  0.46 0.3482
Night 0.31  0.44 0.28  0.50 0.6787
Cough
Day 1.17  0.65 0.71  0.49 0.0034*
Night 1.09  0.76 0.76  0.71 0.0192*
Sleep quality 0.66  0.67 0.47  0.56 0.0773
Daytime sleep 0.21  0.41 0.12  0.31 0.2125
Activity 0.09  0.23 0.05  0.23 0.4982
Data are expressed as mean  SD.
* Significant difference between baseline and Wk 3 at a level
of 0.05 (Wilcoxon signed rank test).
Table 4 Improvement in total symptom score in the irri-
gation group (n Z 29)
Symptom Wk 1 Wk 3 p
Eye itching
Day 0.37  0.61 0.35  0.55 0.6189
Night 0.39  0.59 0.34  0.60 0.4064
Tears
Day 0.06  0.21 0.05  0.20 1.0000
Night 0.10  0.35 0.07  0.24 0.4652
Eye congestion
Day 0.21  0.54 0.12  0.35 0.0280*
Night 0.18  0.53 0.11  0.31 0.4652
Rhinorrhea
Day 0.85  0.67 0.57  0.65 0.0331*
Night 0.79  0.61 0.47  0.54 0.0049*
Nasal congestion
Day 0.71  0.71 0.58  0.52 0.2373
Night 0.66  0.75 0.61  0.65 0.9611
Nasal itching
Day 0.62  0.68 0.46  0.58 0.0238*
Night 0.64  0.67 0.38  0.56 0.0057*
Sneezing
Day 0.65  0.62 0.42  0.54 0.0052*
Night 0.51  0.66 0.37  0.54 0.1490
Throat itching
Day 0.07  0.14 0.07  0.18 0.9049
Night 0.15  0.29 0.06  0.20 0.0966
Cough
Day 0.98  0.61 0.52  0.46 0.0008*
Night 0.87  0.56 0.44  0.43 0.0005*
Sleep quality 0.31  0.53 0.26  0.46 0.3648
Daytime sleep 0.31  0.55 0.18  0.48 0.0850
Activity 0.01  0.04 0.00  0.00 0.1573
Data are expressed as mean  SD.
* Significant difference between baseline and Wk 3 at a level
of 0.05 (Wilcoxon signed rank test).
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groups. However, the nasal irrigation group experienced
effective relief of sinonasal disease symptoms and
improved allergic-related symptoms. Nasal irrigation may
directly cleanse the nasal mucosa and remove inflammatory
mediators. Therefore, the severity of sinonasal symptoms
was not associated with changes in nasal eosinophil and
neutrophil counts associated with inflammatory mediators
and allergens. Although we did not measure inflammatory
mediators and allergens in nasal secretions, this will be
considered in a future study.
Cotton swabs were used to collect nasal smear speci-
mens. This is a simple and inexpensive method, but false-
positive and false-negative results are common. Better
and more accurate results may be obtained if nasal
smears are taken with a rhinoprobe rather than a cotton
swab.
Some prospective nasal irrigation studies have shown
decreases in medication use overall,22 and specifically
antibiotic use.24 Our study design included antibiotic
treatment for all participants during the study. Therefore,
we did not measure any decreases in medication use in theirrigation group. In future studies, we will focus on short-
term use of antibiotics for sinusitis.
Our study is limited by the relatively small sample size,
undefined compliance rate, times per day of nasal irriga-
tion, and differences in disease severity. We did not
measure IgE or other serology parameters. Computed
tomography (CT) is better than Water’s projection radiog-
raphy for sinus assessment; however, CT would have added
the risk of radiation and increased the cost of performing
the study. In addition, the nature of our study did not allow
blinding, although we were diligent in our efforts to
prevent any experimental bias. The methodological
strengths of the study include low missing-data rates, a low
drop-out rate, additional testing such as nPEFR and radio-
graphic imaging, and a young mean age.
In conclusion, our study shows that nasal irrigation
isotonic saline improves the quality of life for pediatric
rhinoconjunctivitis and decreases acute sinusitis and
allergic-related symptoms. Nasal irrigation is an inexpen-
sive and effective adjunctive treatment for acute sinusitis
in atopic children. Larger and longer extended studies to
assess the conclusion are warranted.
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